|6.98||+0.18 / +2.65%|
As of Aug 27
|7.29||+0.31 / +4.44%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 17.00. The median estimate represents a +186.53% increase from the last price of 6.98.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.